Article
Licensed
Unlicensed Requires Authentication

Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren’s syndrome patients

  • and EMAIL logo
Published/Copyright: October 28, 2011

Abstract

Background: Patients with primary Sjögren’s syndrome (pSS) mostly have high levels of polyclonal immunoglobulin (IgG) and selective increase of IgG subclasses. As IgG subclasses profiles represent specific immunological processes and may be indicative of the underlying pathological pattern in pSS, it would be of great clinical importance to investigate the distribution of IgG subclasses in pSS patients.

Methods: In archived sera from 155 patients with pSS, 50 patients with systemic lupus erythematosus (SLE) and 50 normal controls were analyzed by immunonephelometric assay.

Results: The median levels of IgG1, IgG2, IgG3 and IgG4 in pSS patients were 11300 mg/L, 6130 mg/L, 961 mg/L and 142 mg/L, respectively. When compared with the normal controls, significant increases of IgG1 (p<0.001), IgG2 (p<0.001) and IgG3 (p<0.001) was observed in pSS patients, while the IgG4 level was significantly decreased (p=0.002). The ratio of IgG1/IgG2 in pSS patients was 2.3±1.4, which was significantly higher than that in the normal controls (p<0.001). When the pSS patients were divided into different groups, a higher level of IgG3 was observed in pSS with systematic disorders (p=0.008). In addition, the level of IgG1 was statistically higher in the anti-Ro or anti-La positive group than that in the negative group (p<0.001), but the IgG4 concentration was lower than that in the negative group (p=0.046). A significant positive correlation between the concentration of IgG3 and the disease duration (p<0.001) was also identified.

Conclusions: The data supported the pathogenic role of IgG1 and IgG3 subclasses in the process of pSS. Further investigations to elucidate the reasons for the increase of IgG2 and whether IgG2 has any contribution to the pathogenesis of pSS are needed.


Corresponding author: Jinming Li, National Center for Clinical Laboratories, Beijing Hospital, No. 1 Dahua Road, Dongdan, Beijing 100730, PR China Phone: +86-10-58115053, Fax: +86-10-65212064

Received: 2011-7-17
Accepted: 2011-10-3
Published Online: 2011-10-28
Published in Print: 2012-02-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorials
  2. Biological variation and reference change values: an essential piece of the puzzle of laboratory testing
  3. Copeptin for acute coronary syndrome: diamond or decoy?
  4. Reviews
  5. Gold nanoparticles in the clinical laboratory: principles of preparation and applications
  6. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)
  7. Mini Review
  8. From “Clinical Proteomics” to “Clinical Chemistry Proteomics”: considerations using quantitative mass-spectrometry as a model approach
  9. Opinion Paper
  10. Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin
  11. Perspectives
  12. Do genome-wide association scans have potential for translation?
  13. Genetics and Molecular Diagnostics
  14. Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma
  15. Evaluation of Maxwell® 16 for automated DNA extraction from whole blood and formalin-fixed paraffin embedded (FFPE) tissue
  16. Screening for mutations in the α-globin genes leading to abnormal hemoglobin variants with high resolution melting analysis
  17. Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene
  18. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) –482C>T polymorphism on triglyceride concentration in Turkish adults
  19. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients
  20. Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods
  21. Functional polymorphisms of GSTA1 and GSTO2 genes associated with asthma in Italian children
  22. General Clinical Chemistry and Laboratory Medicine
  23. Optimisation of whole blood and plasma manganese assay by ICP-MS without use of a collision cell
  24. Quantitative performance of antibody array technology in a prenatal screening setting
  25. A comparison of the acute effects of calcium and strontium ranelate on the serum marker of bone resorption
  26. A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiency
  27. Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren’s syndrome patients
  28. Development of control material for hemoglobin analysis
  29. Evaluation of nucleated red blood cells in the peripheral blood of hematological diseases
  30. The effect of hematocrit on the results of measurements using glucose meters based on different techniques
  31. Lupus anticoagulant testing: analyzing fresh samples after a single centrifugation and after a 6–8 h delay
  32. Pseudoeosinophilia of synovial fluid is caused by crystals mimicking the distinct light scattering fractions of eosinophilic granules
  33. The effect of acidification and oxalate concentration on urine calcium measurements in EQAS materials and patient samples
  34. Cancer Diagnostics
  35. The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease
  36. Cardiovascular Diseases
  37. Heart type fatty acid binding protein in relation to pharmacologic scintigraphy in coronary artery disease
  38. Effects of fibrates on C-reactive protein concentrations: a meta-analysis of randomized controlled trials
  39. Letters to the Editor
  40. Comparison of Bio-Plex measurements with standard techniques
  41. Interference of hemoglobin (Hb) Las Palmas with HPLC measurement of HbA1c in 87 patients
  42. False-positive calcitonin results in patients with benign goiter
  43. Erratum
  44. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
  45. Congress Abstracts
  46. Advances and Controversies in B-Vitamins and Choline
  47. Prelims
Downloaded on 12.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.771/html
Scroll to top button